BISTTRY07:00Live
GENIL Balance Sheet and Financial StatementsGen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş.
Main MarketChemicals, Petroleum, Rubber and Plastics
4.670.00 (0.00%)
- Previous close
- 4.67
- Market cap
- TRY 21B
Last updated: Source: Borsa Istanbul, 15-minute delayed
The latest reported financial period for GENIL is 2026/6. The table lists the last 5 periods from newest to oldest.
Quarterly, annualised and cumulative sales, EBITDA, net profit, assets, liabilities and equity series for Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. (GENIL), derived from KAP financial reports. Amounts are in TRY.
Financials
| Period | Sales (Quarterly, TRY) | EBITDA (Quarterly, TRY) | Net profit (Quarterly, TRY) |
|---|---|---|---|
| 2026/6 | 7.4B | 855.4M | 516.6M |
| 2026/3 | 6.6B | 1.3B | 375.1M |
| 2025/12 | 4.8B | 346.8M | 295.2M |
| 2025/9 | 3.3B | 450.9M | 113.2M |
| 2025/6 | 6B | 640.6M | 132.1M |
Frequently Asked Questions
How much profit did GENIL report in its latest statements?
In the latest period (2026/6) GENIL reported a net profit of TRY 516.6M, sales of TRY 7.4B and EBITDA of TRY 855.4M.
What does annualised mean?
Annualised values sum the last four quarters, giving a seasonally neutral twelve-month figure used in ratios such as P/E and EV/EBITDA.